20 results
8-K
EX-10.1
ORTX
Orchard Therapeutics plc
6 Oct 22
Entry into a Material Definitive Agreement
4:34pm
or entity onto Company premises or into Company workspaces.
4. Commitment to Company; Avoidance of Conflict of Interest. While an employee … of the Company or his or her designee at such time as any activity of either the Company or another business presents me with a conflict of interest
8-K
EX-10.1
7kfcnpr
9 Feb 21
Orchard Therapeutics Announces $150 Million Strategic Financing
7:10am
8-K
EX-3.1
jyz8lhc
19 Jun 20
Amendments to Articles of Incorporation or Bylaws
4:09pm
10-Q
EX-10.1
94red2smsjpn
7 May 20
Quarterly report
4:03pm
DEF 14A
zuxlo5gbue3vvgp 3qr
29 Apr 20
Definitive proxy
4:02pm
PRE 14A
vkwi330s4m jf5qst
14 Apr 20
Preliminary proxy
4:46pm
10-K
EX-10.15
gswcudf2ozuw i94u3x1
27 Feb 20
Annual report
4:02pm
10-K
EX-10.16
jiqs oph0
27 Feb 20
Annual report
4:02pm
10-K
EX-10.14
ccrsj 6en
27 Feb 20
Annual report
4:02pm
20-F
EX-1.1
erqr1hxjbrb3fj88lp
22 Mar 19
Annual report (foreign)
8:02am
F-1/A
EX-10.5
l65wx3tcl q1kmzdn35
23 Oct 18
Registration statement (foreign) (amended)
6:15am
F-1/A
EX-3.1
h6j qcz2hkaai9zc
23 Oct 18
Registration statement (foreign) (amended)
6:15am
F-1/A
EX-10.11
uoeap w9vev8uqijj3m
23 Oct 18
Registration statement (foreign) (amended)
6:15am
F-1
EX-10.5
hjwtlzmge
4 Oct 18
Registration statement (foreign)
4:48pm
DRS
EX-10.5
a6jqj7a04fu 2z
6 Aug 18
Draft registration statement
12:00am
- Prev
- 1
- Next